Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury
- 1 January 2009
- journal article
- Published by Informa UK Limited in Brain Injury
- Vol. 23 (6), 577-584
- https://doi.org/10.1080/02699050902926317
Abstract
Traumatic brain injury is highly associated with the over-production of reactive oxygen species. The aim of this study was to investigate the putative neuroprotective effect of montelukast, a cysteinyl-leukotriene receptor antagonist, in a rat model of traumatic brain injury (TBI).Sprague Dawley rats were subjected to TBI with a weight-drop device using 300 g-1 m weight-height impact. The groups were: control (saline), montelukast (10 mg kg(-1) per day, ip), trauma and trauma + montelukast. Two days post-trauma, neurological examination scores were measured and animals were decapitated and the brain tissues were taken for the histologic and biochemical [malondialdehyde (MDA)-an index for lipid peroxidation, reduced glutathione (GSH), myeloperoxidase (MPO)-an index for neutrophil infiltration and Na+/K+-ATPase activity] evaluations. Brain oedema and blood-brain barrier (BBB) permeability were also evaluated.The neurological examination scores mildly increased in trauma groups at 48 hours. Although the scores were decreased in the montelukast treated group, they were still significantly higher than the control. The trauma caused a significant increase in brain water content and Evans blue (EB) extravasation. Montelukast treatment reduced BBB permeability. It also decreased lipid peroxidation and MPO activity.The present study suggests that montelukast may have beneficial effects against TBI-induced oxidative stress of the brain.Keywords
This publication has 34 references indexed in Scilit:
- Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injuryFree Radical Biology & Medicine, 2008
- Traumatic brain injury: Can the consequences be stopped?CMAJ : Canadian Medical Association Journal, 2008
- Effects of zileuton and montelukast in mouse experimental spinal cord injuryBritish Journal of Pharmacology, 2008
- Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expressionBiochemical and Biophysical Research Communications, 2006
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptorThe EMBO Journal, 2006
- Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell deathBiochemical and Biophysical Research Communications, 2006
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumorsActa Pharmacologica Sinica, 2005
- Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumorsNeuroscience Letters, 2004
- Neutrophils, Endothelial Cells, and Cysteinyl Leukotrienes: A New Approach to Neutrophil-Dependent Inflammation?Biochemical and Biophysical Research Communications, 2001